» Articles » PMID: 1283998

The Lipooligosaccharide Immunotype As a Virulence Determinant in Neisseria Meningitidis

Overview
Journal Microb Pathog
Date 1992 Sep 1
PMID 1283998
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

We have studied the antigenic (immunotype) and physical characteristics of the lipooligosaccharide (LOS) of epidemiologically related Neisseria meningitidis case (36) and carrier (76) isolates associated with a virulent clone of meningococci (ET-5 complex). LOS immunotypes were determined by dot blotting using immunotype specific monoclonal antibodies and physical characteristics were determined from silver stained SDS-PAGE following proteinase K digestion. The genetic similarity of the different isolates was confirmed by analysis of the restriction fragment length polymorphisms. An association between LOS immunotype expression and invasive disease was found; 97% of case isolates expressed the L3,7,9 immunotype, of which 13% additionally expressed the L1,8,10 determinant. The LOS immunotypes of carrier strains were much more heterogeneous. The predominant immunotype was L1,8,10 (70%) and only 24% expressed L3,7,9 alone. Genotypically related case isolates from Norway (6) and Austria (18) expressed the L3,7,9 immunotype with similar frequency to the U.K. isolates. The combination of LOS immunotype and capsule expression appears to be related to the virulence of these meningococcal strains.

Citing Articles

: analysis of pili and LPS in emerging Brazilian strains.

Portilho A, Trzewikoswki de Lima G, De Gaspari E Ther Adv Vaccines Immunother. 2020; 8:2515135520919195.

PMID: 32435751 PMC: 7225800. DOI: 10.1177/2515135520919195.


Fitness Cost of Rifampin Resistance in Neisseria meningitidis: In Vitro Study of Mechanisms Associated with rpoB H553Y Mutation.

Colicchio R, Pagliuca C, Pastore G, Cicatiello A, Pagliarulo C, Tala A Antimicrob Agents Chemother. 2015; 59(12):7637-49.

PMID: 26416867 PMC: 4649176. DOI: 10.1128/AAC.01746-15.


The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.

Pinto V, Burden R, Wagner A, Moran E, Lee C PLoS One. 2013; 8(11):e79304.

PMID: 24244473 PMC: 3828347. DOI: 10.1371/journal.pone.0079304.


Meningococcal disease and the complement system.

Lewis L, Ram S Virulence. 2013; 5(1):98-126.

PMID: 24104403 PMC: 3916388. DOI: 10.4161/viru.26515.


Opc expression, LPS immunotype switch and pilin conversion contribute to serum resistance of unencapsulated meningococci.

Hubert K, Pawlik M, Claus H, Jarva H, Meri S, Vogel U PLoS One. 2012; 7(9):e45132.

PMID: 23028802 PMC: 3447861. DOI: 10.1371/journal.pone.0045132.